vs
Guardian Pharmacy Services, Inc.（GRDN）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
Guardian Pharmacy Services, Inc.的季度营收约是LifeStance Health Group, Inc.的1.0倍（$397.6M vs $382.2M），Guardian Pharmacy Services, Inc.净利率更高（5.3% vs 3.1%，领先2.2%）
CVS药房是美国零售企业，为CVS健康旗下子公司，总部位于罗德岛州文索基特，前身为Consumer Value Stores，1963年在马萨诸塞州洛厄尔成立，是美国知名的零售药房服务提供商，在药品零售、健康服务领域拥有广泛的业务布局。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
GRDN vs LFST — 直观对比
营收规模更大
GRDN
是对方的1.0倍
$382.2M
净利率更高
GRDN
高出2.2%
3.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $397.6M | $382.2M |
| 净利润 | $20.9M | $11.7M |
| 毛利率 | 21.5% | — |
| 营业利润率 | 7.7% | 4.7% |
| 净利率 | 5.3% | 3.1% |
| 营收同比 | — | 17.4% |
| 净利润同比 | — | 264.1% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GRDNLFST
| Q4 25 | $397.6M | $382.2M | ||
| Q3 25 | $377.4M | $363.8M | ||
| Q2 25 | $344.3M | $345.3M | ||
| Q1 25 | $329.3M | $333.0M | ||
| Q4 24 | — | $325.5M | ||
| Q3 24 | $314.4M | $312.7M | ||
| Q2 24 | — | $312.3M | ||
| Q1 24 | — | $300.4M |
净利润GRDNLFST
| Q4 25 | $20.9M | $11.7M | ||
| Q3 25 | $9.8M | $1.1M | ||
| Q2 25 | $9.0M | $-3.8M | ||
| Q1 25 | $9.4M | $709.0K | ||
| Q4 24 | — | $-7.1M | ||
| Q3 24 | $-122.0M | $-6.0M | ||
| Q2 24 | — | $-23.3M | ||
| Q1 24 | — | $-21.1M |
毛利率GRDNLFST
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率GRDNLFST
| Q4 25 | 7.7% | 4.7% | ||
| Q3 25 | 4.3% | 2.0% | ||
| Q2 25 | 3.7% | -0.9% | ||
| Q1 25 | 3.9% | 0.5% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | -33.3% | 0.0% | ||
| Q2 24 | — | -5.1% | ||
| Q1 24 | — | -5.6% |
净利率GRDNLFST
| Q4 25 | 5.3% | 3.1% | ||
| Q3 25 | 2.6% | 0.3% | ||
| Q2 25 | 2.6% | -1.1% | ||
| Q1 25 | 2.9% | 0.2% | ||
| Q4 24 | — | -2.2% | ||
| Q3 24 | -38.8% | -1.9% | ||
| Q2 24 | — | -7.5% | ||
| Q1 24 | — | -7.0% |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $65.6M | $248.6M |
| 总债务越低越好 | $0 | $282.8M |
| 股东权益账面价值 | $217.9M | $1.5B |
| 总资产 | $412.7M | $2.2B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资GRDNLFST
| Q4 25 | $65.6M | $248.6M | ||
| Q3 25 | $36.5M | $203.9M | ||
| Q2 25 | $18.8M | $188.9M | ||
| Q1 25 | $14.0M | $134.3M | ||
| Q4 24 | — | $154.6M | ||
| Q3 24 | $37.2M | $102.6M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $49.5M |
总债务GRDNLFST
| Q4 25 | $0 | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | $34.3M | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
股东权益GRDNLFST
| Q4 25 | $217.9M | $1.5B | ||
| Q3 25 | $195.5M | $1.5B | ||
| Q2 25 | $179.7M | $1.5B | ||
| Q1 25 | $163.2M | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $133.9M | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
总资产GRDNLFST
| Q4 25 | $412.7M | $2.2B | ||
| Q3 25 | $390.0M | $2.1B | ||
| Q2 25 | $356.3M | $2.1B | ||
| Q1 25 | $334.0M | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $348.0M | $2.1B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.1B |
负债/权益比GRDNLFST
| Q4 25 | 0.00× | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | 0.26× | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.6M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | — | $46.6M |
| 自由现金流率自由现金流/营收 | — | 12.2% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | 1.65× | 4.93× |
| 过去12个月自由现金流最近4个季度 | — | $110.0M |
8季度趋势，按日历期对齐
经营现金流GRDNLFST
| Q4 25 | $34.6M | $57.6M | ||
| Q3 25 | $28.2M | $27.3M | ||
| Q2 25 | $19.9M | $64.4M | ||
| Q1 25 | $17.6M | $-3.1M | ||
| Q4 24 | — | $62.3M | ||
| Q3 24 | — | $22.7M | ||
| Q2 24 | — | $44.1M | ||
| Q1 24 | — | $-21.8M |
自由现金流GRDNLFST
| Q4 25 | — | $46.6M | ||
| Q3 25 | $24.2M | $17.0M | ||
| Q2 25 | — | $56.6M | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | — | $56.0M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | — | $39.0M | ||
| Q1 24 | — | $-26.9M |
自由现金流率GRDNLFST
| Q4 25 | — | 12.2% | ||
| Q3 25 | 6.4% | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | -3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | -9.0% |
资本支出强度GRDNLFST
| Q4 25 | — | 2.9% | ||
| Q3 25 | 1.1% | 2.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.7% |
现金转化率GRDNLFST
| Q4 25 | 1.65× | 4.93× | ||
| Q3 25 | 2.87× | 25.34× | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
